PerkinElmer scoops up German diagnostics company for $1.3B
It's a sign of the times: PerkinElmer has acquired Euroimmun, a diagnostics company with a strong market presence in China and other emerging markets.
It's a sign of the times: PerkinElmer has acquired Euroimmun, a diagnostics company with a strong market presence in China and other emerging markets.
Nine out of 10 large pharma companies spend more on marketing than they do on R&D. It's a statistic often cited as a sign of industry greed, but it may be the best way to foster real innovation.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.